Rodinir kaps. 300 mg No. 10

Rodinir capsules are shown for treatment of infections easy and moderate severity, caused by sensitive microorganisms.

Community-acquired pneumonia caused:

• Haemophilus influenzae (including the strains producing beta lactamazu);
• Haemophilus parainfluenzae (including the strains producing beta lactamazu);
• Streptococcus pneumonia (only the strains sensitive to penicillin);
• Moraxella catarrhalis (including the strains producing beta lactamazu).

Exacerbation of chronic bronchitis, is caused:

• Haemophilus influenzae (including the strains producing beta lactamazu);
• Haemophilus parainfluenzae (including the strains producing beta lactamazu);
• Streptococcus pneumonia (only the strains sensitive to penicillin);
• Moraxella catarrhalis (including the strains producing beta lactamazu).

Acute sinusitis caused:

• Haemophilus influenzae (including the strains producing beta lactamazu);
• Streptococcus pneumonia (only the strains sensitive to penicillin);
• Moraxella catarrhalis (including the strains producing beta lactamazu).

Pharyngitis/tonsillitis caused: Streptococcus pyogenes.

Uncomplicated infections of skin and soft tissues caused:

• Staphylococcus aureus (including the strains producing beta lactamazu);
• Streptococcus pyogenes.

Structure

Active ingredient: cefdinir;

1 solid capsule contains a tsefdinira of 300 mg;

Excipients: calcium of a karmelloz, polyoxide 40 stearate, silicon dioxide colloidal, magnesium stearate solid gelatin capsule: ferrous oxide black (E172), titan dioxide (E 171), gelatin.

Contraindication

Hypersensitivity to a tsefdinir, other cephalosporins and other components of drug.

by

for oral administration. Capsules can be accepted irrespective of meal.

Pregnant

not to apply

Feature of use

Medicine to apply

to children aged from 13 years.

Drivers

does not influence.

Overdose

Data on overdose of a tsefdinir at the person.

Side effects

it is frequent - diarrhea, vaginal candidiasis, nausea, a headache, an abdominal pain, a vaginitis.

Infrequently - rash, dyspepsia, a meteorism, vomiting, changes in excrements, anorexia, a constipation, dizziness, dryness in a mouth, an asthenia, insomnia, a leukorrhea, candidiasis, an itching, drowsiness.

Simultaneous use with antacids reduces

With _max and extent of absorption of a tsefdinir approximately for 40%. Achievement time With _max also lasts for 1 hour. At simultaneous use of these means tsefdinir it is necessary to accept at least in 2 hours prior to or in 2 hours after reception of antacids.

to

It was reported about cases of a reddish color of a chair at the patients accepting tsefdinir. In many cases the patients applied at the same time ferriferous products. Red coloring can be connected with education in a digestive tract of a complex of a tsefdinir or products of its decomposition and iron, is not soaked up.

Storage conditions

to Store

at a temperature not above 25 °C out of children's reach.

Expiration date - 3 years.